文献检索/Therapeutics and Clinical Risk ManagementEM-T3Therapeutics and Clinical Risk Management2017-10-01第 Volume 13 卷，1423-1437开放获取高影响力 · 前 10%Understanding the positive benefit:risk profile of alemtuzumab in relapsing multiple sclerosis: perspectives from the Alemtuzumab Clinical Development ProgramEva HavrdováCharles UniversityJeffrey A. CohenCleveland ClinicDana HorákováCharles UniversityIvana KovářováCharles UniversityEva MeluzínováCharles University开放获取全文去出版社页面 引用论文图谱收藏 被引提醒分享打印登录后看摘要和中文要点英文摘要、AI 生成的中文摘要和三条要点、参考文献和引证文献列表、论文图谱，注册免费。登录 / 注册关键词alemtuzumabrelapsing-remitting multiple sclerosisbenefit-risk profileinterferon beta-1ainfusion reactionscorticosteroid pretreatmentautoimmune adverse eventspapillary thyroid carcinomamelanomacancer risksafety monitoringidiopathic thrombocytopenic purpurakidney diseasebrain atrophyno evidence of disease activity参考文献69引证文献1相似文献引文网络关联作者相关机构登录后可以看完整列表。去登录论文图谱本篇和它的参考文献、引证文献、相似文献登录后可以看这篇的论文图谱：谁被它引用、谁引用了它、还有哪些相似的研究。登录 / 注册
